Sally Ross

Sally Ross

Company: iTeos Therapeutics

Job title: Project Head


Can Biomarkers Be Used to Identify Patients Who Are Most Likely to Benefit from Adenosine-Pathway Targeted Cancer Immunotherapy? 12:10 pm

• Discussing the role of adenosine in the tumor microenvironment • Divulging biomarkers as surrogates for the presence of adenosine • Highlighting the A2AR as a biomarker for response to inupadenant in iTeos clinical trialsRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.